CX 2018 Presentations

Please note: Some presentations may not be available as permission may not have been given.

ACUTE STROKE CONTROVERSIES - Friday, 27th April
Venue:   Upper Main Auditorium
Time: 08:00 - 12:30
Carotid controversies
Chairing:   Ross Naylor, Leicester, United Kingdom
Moderator:   Hugh Markus, Cambridge, United Kingdom
Time: 08:00 - 08:12
CX Debate: Carotid endarterectomy is safer than carotid artery stenting in the early time period after onset of symptoms

For the motion
Time: 08:00 - 08:06
Barbara Rantner, Innsbruck, Austria
CLICK HERE TO VIEW VIDEO

Against the motion
Time: 08:06 - 08:12
Peter Schneider, Honolulu, United States
CLICK HERE TO VIEW VIDEO

Time: 08:12 - 08:24
Audience participation, discussion and polling
Time: 08:24 - 08:36
CX Debate: Routine completion assessment is essential after carotid endarterectomy

For the motion
Time: 08:24 - 08:30
Hans-Henning Eckstein, Munich, Germany
CLICK HERE TO VIEW VIDEO

Against the motion
Time: 08:30 - 08:36
Alun Davies, London, United Kingdom
CLICK HERE TO VIEW VIDEO

Time: 08:36 - 08:48
Audience participation, discussion and polling
Time: 08:48 - 09:00
CX Debate: The majority of patients neither require surveillance nor reintervention after CAS/CAE

For the motion
Time: 08:48 - 08:54
Ross Naylor, Leicester, United Kingdom
CLICK HERE TO VIEW VIDEO

Against the motion
Time: 08:54 - 09:00
William Gray, Wynnewood, United States
CLICK HERE TO VIEW VIDEO

Time: 09:00 - 09:12
Audience participation, discussion and polling
Time: 09:12 - 09:24
CX Debate: Only patients with recurrent vertebrobasilar symptoms should be considered for vertebral artery stenting-the majority can be treated medically

For the motion
Time: 09:12 - 09:18
Hugh Markus, Cambridge, United Kingdom
CLICK HERE TO VIEW VIDEO

Against the motion
Time: 09:18 - 09:24
Nick Hopkins, Buffalo, United States
CLICK HERE TO VIEW VIDEO

Time: 09:24 - 09:36
Audience participation, discussion and polling
Time: 09:36 - 09:48
CX Debate: There is no role for screening to detect asymptomatic carotid stenosis

For the motion
Time: 09:36 - 09:42
Rao Vallabhaneni, Liverpool, United Kingdom
CLICK HERE TO VIEW VIDEO

Against the motion
Time: 09:42 - 09:48
Andrew Nicolaides, Nicosia, Cyprus

Time: 09:48 - 10:00
Audience participation, discussion and polling
 
Coffee
Time: 10:00 - 10:30
CONTROVERSIES PANEL
Chairing:   Hugh Markus, Cambridge, United Kingdom
Moderator:   Ross Naylor, Leicester, United Kingdom
Time: 10:30 - 10:37
US SCAFFOLD clinical study-novel stent results at 12 months
Speaker:   William Gray, Wynnewood, United States
Time: 10:37 - 10:44
Audience participation and discussion
Time: 10:44 - 10:51
Is there a role for CEA/CAS in patients with severe carotid stenoses undergoing major non-cardiac surgery?
Speaker:   Gert Jan de Borst, Utrecht, Netherlands
Audience participation and discussion
Time: 10:58 - 11:05
Is there a role for CEA or CAS in preventing dementia?
Speaker:   Charles McCollum, Manchester, United Kingdom
Time: 11:05 - 11:12
Audience participation and discussion
Time: 11:12 - 11:19
Is protamine reversal of heparin safe during CEA?
Speaker:   John Kakisis, Athens, Greece
Time: 11:19 - 11:26
Audience participation and discussion
 
Cerebral and vertebral controversies
Time: 11:26 - 11:33
Quantitative analysis of embolic filter debris load during CAS in asymptomatic patients
Speaker:   Franco Grego, Padua, Italy
Time: 11:33 - 11:40
An alternative interpretation of the SAMMPRIS trial findings
Speaker:   Nick Hopkins, Buffalo, United States
Time: 11:40 - 11:50
Audience participation and discussion
Time: 11:50 - 11:57
Distribution of gas during thoracic endovascular aortic repair in an aortic flow model
Time: 11:57 - 12:04
Carotid endarterectomy in asymptomatic patients, using a standardised technique based in routine “delayed&lrquo; shunting
Speaker:   Michele Piazza, Padua, Italy
Time: 12:04 - 12:11
The role of VWF, ADAMTS13 and inflammatory response in the outcome of acute ischaemic stroke mechanical thrombectomy procedure
Speaker:   Vaclav Prochazka, Ostrava, Czech Republic
Time: 12:11 - 12:20
Audience participation and discussion